Toxoplasma gondii by PCR
Ordering Recommendation
Confirm toxoplasmosis infection in immunocompromised hosts as well as fetuses and newborns. May be used to confirm equivocal antibody testing.
New York DOH Approval Status
Specimen Required
Lavender (EDTA), pink (K2EDTA) or serum separator tube. OR Amniotic fluid, CSF, ocular fluid or tissue.
Separate serum or plasma from cells. Transfer 1 mL serum, plasma, amniotic fluid, CSF or ocular fluid to a sterile container. (Min: 0.5 mL) OR Tissue: Transfer to a sterile container and freeze immediately.
Frozen.
Heparinized specimens, tissues in optimal cutting temperature compound.
Specimen source required.
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 3 months
All Others: Ambient: 8 hours; Refrigerated: 5 days; Frozen: 3 months
Methodology
Qualitative Polymerase Chain Reaction
Performed
Tue, Fri
Reported
1-5 days
Reference Interval
Interpretive Data
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
Hotline History
CPT Codes
87798
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0050112 | Toxoplasma gondii Source | 31208-2 |
0055591 | Toxoplasma gondii by PCR | 29904-0 |
Aliases
- Coccidia
- T gondi DNA detection
- T. gondii PCR
- Toxoplasma gondii, Molecular Detection, PCR